blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1234834

EP1234834 - 1,3,4-OXADIAZOLIN-2-ONE DERIVATIVES AND DRUGS CONTAINING THESE DERIVATIVES AS THE ACTIVE INGREDIENT [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.08.2004
Database last updated on 11.09.2024
Most recent event   Tooltip13.08.2004Application deemed to be withdrawnpublished on 29.09.2004  [2004/40]
Applicant(s)For all designated states
ONO PHARMACEUTICAL CO., LTD.
1-5, Doshomachi 2-chome Chuo-ku
Osaka-shi, Osaka 541-8526 / JP
[N/P]
Former [2002/35]For all designated states
ONO PHARMACEUTICAL CO., LTD.
1-5, Doshomachi 2-chome, Chuo-ku
Osaka-shi, Osaka 541-8526 / JP
Inventor(s)01 / OHMOTO, Kazuyuk, c/o Ono Pharmaceutical Co., Ltd.
1-1, Sakurai 3-chome, Shimamoto-cho
Mishima-gun Osaka 618-858 / JP
02 / OKUMA, Motohiro, c/o Ono Pharmaceutical Co., Ltd.
1-1, Sakurai 3-chome, Shimamoto-cho
Mishima-gun Osaka 618-858 / JP
03 / SEKIOKA, Tomohiko, c/o Ono Pharmaceutical Co., Ltd.
1-1, Sakurai 3-chome, Shimamoto-cho
Mishima-gun Osaka 618-858 / JP
 [2002/47]
Former [2002/35]01 / OHMOTO, Kazuyuk, Minase Research Institute
Ono Pharmaceutical Co., Ltd. 1-1, Sakurai 3-chome
Shimamoto-cho, Mishima-gun Osaka 618-858 / JP
02 / OKUMA, Motohiro, Minase Research Institute
Ono Pharmaceutical Co., Ltd. 1-1, Sakurai 3-chome
Shimamoto-cho, Mishima-gun Osaka 618-858 / JP
03 / SEKIOKA, Tomohiko, Minase Research Institute
Ono Pharmaceutical Co., Ltd. 1-1, Sakurai 3-chome
Shimamoto-cho, Mishima-gun Osaka 618-858 / JP
Representative(s)Henkel & Partner mbB
Patentanwaltskanzlei, Rechtsanwaltskanzlei
Maximiliansplatz 21
80333 München / DE
[N/P]
Former [2002/35]Henkel, Feiler, Hänzel
Möhlstrasse 37
81675 München / DE
Application number, filing date00978052.901.12.2000
[2002/35]
WO2000JP08516
Priority number, dateJP1999034445003.12.1999         Original published format: JP 34445099
[2002/35]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0140263
Date:07.06.2001
Language:EN
[2001/23]
Type: A1 Application with search report 
No.:EP1234834
Date:28.08.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 07.06.2001 takes the place of the publication of the European patent application.
[2002/35]
Search report(s)International search report - published on:JP07.06.2001
(Supplementary) European search report - dispatched on:EP16.12.2002
ClassificationIPC:C07K5/083, A61K38/06, A61P1/02, A61P1/04, A61P9/10, A61P11/00, A61P29/00, A61P43/00
[2002/35]
CPC:
C07K5/1027 (EP,US); C07K5/0804 (KR); A61P1/02 (EP);
A61P1/04 (EP); A61P11/00 (EP); A61P29/00 (EP);
A61P43/00 (EP); A61P9/10 (EP); C07K5/101 (EP,US);
A61K38/00 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/35]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:DERIVATE DES 1,3,4-OXADIAZOLIN-2-ON UND MEDIKAMENTE, DIE DIESE DERIVATE ALS AKTIVE SUBSTANZEN ENTHALTEN[2002/35]
English:1,3,4-OXADIAZOLIN-2-ONE DERIVATIVES AND DRUGS CONTAINING THESE DERIVATIVES AS THE ACTIVE INGREDIENT[2002/35]
French:DERIVES DE 1,3,4-OXADIAZOLINE-2-ONE ET MEDICAMENTS CONTENANT CES DERIVES UTILES COMME INGREDIENT ACTIF[2002/35]
Entry into regional phase28.05.2002Translation filed 
28.05.2002National basic fee paid 
28.05.2002Search fee paid 
28.05.2002Designation fee(s) paid 
28.05.2002Examination fee paid 
Examination procedure13.06.2001Request for preliminary examination filed
International Preliminary Examining Authority: JP
28.05.2002Examination requested  [2002/35]
31.03.2003Despatch of a communication from the examining division (Time limit: M06)
15.09.2003Reply to a communication from the examining division
13.11.2003Communication of intention to grant the patent
24.03.2004Application deemed to be withdrawn, date of legal effect  [2004/40]
29.04.2004Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2004/40]
Fees paidRenewal fee
12.12.2002Renewal fee patent year 03
12.12.2003Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]EP1234820  (ONO PHARMACEUTICAL CO [JP]) [E] 1,2* page 26, formula (I-1f) *
International search[A]WO9824806  (CORTECH INC [US], et al);
 [A]  - MACIEJ WIECZOREK ET AL., "Biochemical characterization of alpha-ketooxadiazole inhibitors of elastases", ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, (1999), vol. 367, no. 2, pages 193 - 201, XP002937402

DOI:   http://dx.doi.org/10.1006/abbi.1999.1249
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.